Innate immune interactions within the central nervous system modulate pathogenesis of viral infections

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 47-53

  Nair, Sharmila ^a   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOPHAGY PROTEIN 5; BECLIN 1; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2ALPHA; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 18; INTERLEUKIN 1BETA; JANUS KINASE; MICRORNA; MICRORNA 132; MICRORNA 138; MICRORNA 146A; MICRORNA 155; MICRORNA 29B; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; PEPTIDES AND PROTEINS; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; BLOOD BRAIN BARRIER; CALIFORNIA ENCEPHALITIS; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVATION; GENE; GENE EXPRESSION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; IFI27L2A GENE; IN VIVO STUDY; INNATE IMMUNITY; IRG1 GENE; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LA CROSSE VIRUS; NERVE CELL; NONHUMAN; OLIGOMERIZATION; REVIEW; SIGNAL TRANSDUCTION; SINDBIS VIRUS; SINDBIS VIRUS INFECTION; UPREGULATION; VESICULAR STOMATITIS; VESICULOVIRUS; VIRUS ENTRY; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE VIRUS; ANIMAL; CENTRAL NERVOUS SYSTEM INFECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; VIROLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; MICRORNAS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VIRUS DISEASES;

EID: 84936768465     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.06.011     Document Type: Review

References (65)

1. Fields Virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins. D.M. Knipe, M.P. Howley (Eds.).
2. Schweighardt B., Atwood W.J. Virus receptors in the human central nervous system. J Neurovirol 2001, 7:187-195.
3. Wang S., Welte T., McGargill M., Town T., Thompson J., Anderson J.F., Flavell R.A., Fikrig E., Hedrick S.M., Wang T. Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J Immunol 2008, 181:2084-2091.
4. Verma S., Kumar M., Gurjav U., Lum S., Nerurkar V.R. Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology 2010, 397:130-138.
5. Xu Z., Waeckerlin R., Urbanowski M.D., van Marle G., Hobman T.C. West Nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins. PLOS ONE 2012, 7:e37886.
6. Afonso P.V., Ozden S., Cumont M.C., Seilhean D., Cartier L., Rezaie P., Mason S., Lambert S., Huerre M., Gessain A., et al. Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog 2008, 4:e1000205.
7. Ugolini G. Rabies virus as a transneuronal tracer of neuronal connections. Adv Virus Res 2011, 79:165-202.
8. Smith G. Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol 2012, 66:153-176.
9. Samuel M.A., Wang H., Siddharthan V., Morrey J.D., Diamond M.S. Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A 2007, 104:17140-17145.
10. Rudd P.A., Cattaneo R., von Messling V. Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J Virol 2006, 80:9361-9370.
11. Detje C.N., Lienenklaus S., Chhatbar C., Spanier J., Prajeeth C.K., Soldner C., Tovey M.G., Schluter D., Weiss S., Stangel M., et al. Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon Beta producers that protect from lethal encephalitis. J Virol 2015, 89:2731-2738.
12. Charles P.C., Walters E., Margolis F., Johnston R.E. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology 1995, 208:662-671.
13. Kramer-Hammerle S., Rothenaigner I., Wolff H., Bell J.E., Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 2005, 111:194-213.
14. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004, 10:1366-1373.
15. Daniels B.P., Holman D.W., Cruz-Orengo L., Jujjavarapu H., Durrant D.M., Klein R.S. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio 2014, 5. e01476-01414.
16. Sorgeloos F., Kreit M., Hermant P., Lardinois C., Michiels T. Antiviral type I and type III interferon responses in the central nervous system. Viruses 2013, 5:834-857.
17. Lazear H.M., Daniels B.P., Pinto A.K., Huang A.C., Vick S.C., Doyle S.E., Gale M., Klein R.S., Diamond M.S. Interferon-lambda restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med 2015, 7:284ra259.
18. Weber E., Finsterbusch K., Lindquist R., Nair S., Lienenklaus S., Gekara N.O., Janik D., Weiss S., Kalinke U., Overby A.K., et al. Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses. J Virol 2014, 88:12202-12212.
19. Oshiumi H., Okamoto M., Fujii K., Kawanishi T., Matsumoto M., Koike S., Seya T. The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J Immunol 2011, 187:5320-5327.
20. Daffis S., Samuel M.A., Suthar M.S., Gale M., Diamond M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 2008, 82:10349-10358.
21. Zhang S.Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., Segal D., Sancho-Shimizu V., Lorenzo L., Puel A., et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317:1522-1527.
22. Sancho-Shimizu V., Zhang S.Y., Abel L., Tardieu M., Rozenberg F., Jouanguy E., Casanova J.L. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans. Curr Opin Allergy Clin Immunol 2007, 7:495-505.
23. Herman M., Ciancanelli M., Ou Y.H., Lorenzo L., Klaudel-Dreszler M., Pauwels E., Sancho-Shimizu V., Perez de Diego R., Abhyankar A., Israelsson E., et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med 2012, 209:1567-1582.
24. Perez de Diego R., Sancho-Shimizu V., Lorenzo L., Puel A., Plancoulaine S., Picard C., Herman M., Cardon A., Durandy A., Bustamante J., et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 2010, 33:400-411.
25. Reinert L.S., Harder L., Holm C.K., Iversen M.B., Horan K.A., Dagnaes-Hansen F., Ulhoi B.P., Holm T.H., Mogensen T.H., Owens T., et al. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest 2012, 122:1368-1376.
26. Lang K.S., Navarini A.A., Recher M., Lang P.A., Heikenwalder M., Stecher B., Bergthaler A., Odermatt B., Akira S., Honda K., et al. MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus. Eur J Immunol 2007, 37:2434-2440.
27. Town T., Bai F., Wang T., Kaplan A.T., Qian F., Montgomery R.R., Anderson J.F., Flavell R.A., Fikrig E. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 2009, 30:242-253.
28. Welte T., Reagan K., Fang H., Machain-Williams C., Zheng X., Mendell N., Chang G.J., Wu P., Blair C.D., Wang T. Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J Gen Virol 2009, 90:2660-2668.
29. Faul E.J., Wanjalla C.N., Suthar M.S., Gale M., Wirblich C., Schnell M.J. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog 2010, 6:e1001016.
30. Fredericksen B.L., Keller B.C., Fornek J., Katze M.G., Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 2008, 82:609-616.
31. Wollish A.C., Ferris M.T., Blevins L.K., Loo Y.M., Gale M., Heise M.T. An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology 2013, 435:269-280.
32. Nazmi A., Dutta K., Basu A. RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection. PLoS ONE 2011, 6:e21761.
33. Mukherjee P., Woods T.A., Moore R.A., Peterson K.E. Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death. Immunity 2013, 38:705-716.
34. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
35. Li X.D., Wu J., Gao D., Wang H., Sun L., Chen Z.J. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 2013, 341:1390-1394.
36. Daffis S., Samuel M.A., Keller B.C., Gale M., Diamond M.S. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog 2007, 3:e106.
37. Daffis S., Samuel M.A., Suthar M.S., Keller B.C., Gale M., Diamond M.S. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 2008, 82:8465-8475.
38. Christensen J.E., Fenger C., Issazadeh-Navikas S., Krug A., Liljestrom P., Goriely S., Paludan S.R., Finsen B., Christensen J.P., Thomsen A.R. Differential impact of interferon regulatory factor 7 in initiation of the type I interferon response in the lymphocytic choriomeningitis virus-infected central nervous system versus the periphery. J Virol 2012, 86:7384-7392.
39. Menachery V.D., Pasieka T.J., Leib D.A. Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J Virol 2010, 84:9685-9694.
40. Murphy A.A., Rosato P.C., Parker Z.M., Khalenkov A., Leib D.A. Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging. Virology 2013, 444:71-79.
41. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., Michiels T. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 2006, 103:7835-7840.
42. Detje C.N., Meyer T., Schmidt H., Kreuz D., Rose J.K., Bechmann I., Prinz M., Kalinke U. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J Immunol 2009, 182:2297-2304.
43. Fensterl V., Wetzel J.L., Ramachandran S., Ogino T., Stohlman S.A., Bergmann C.C., Diamond M.S., Virgin H.W., Sen G.C. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 2012, 8:e1002712.
44. Yordy B., Iijima N., Huttner A., Leib D., Iwasaki A. A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe 2012, 12:334-345.
45. Rosato P.C., Leib D.A. Intrinsic innate immunity fails to control herpes simplex virus and vesicular stomatitis virus replication in sensory neurons and fibroblasts. J Virol 2014, 88:9991-10001.
46. Cho H., Proll S.C., Szretter K.J., Katze M.G., Gale M., Diamond M.S. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med 2013, 19:458-464.
47. Schneider W.M., Chevillotte M.D., Rice C.M. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 2014, 32:513-545.
48. Cho H., Shrestha B., Sen G.C., Diamond M.S. A role for Ifit2 in restricting West Nile virus infection in the brain. J Virol 2013, 87:8363-8371.
49. Szretter K.J., Brien J.D., Thackray L.B., Virgin H.W., Cresswell P., Diamond M.S. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J Virol 2011, 85:11557-11566.
50. Samuel M.A., Whitby K., Keller B.C., Marri A., Barchet W., Williams B.R., Silverman R.H., Gale M., Diamond M.S., PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons J Virol 2006, 80:7009-7019.
51. Ramos H.J., Lanteri M.C., Blahnik G., Negash A., Suthar M.S., Brassil M.M., Sodhi K., Treuting P.M., Busch M.P., Norris P.J., et al. IL-1beta signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog 2012, 8:e1003039.
52. Kumar M., Roe K., Orillo B., Muruve D.A., Nerurkar V.R., Gale M., Verma S. Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis. J Virol 2013, 87:3655-3667.
53. Durrant D.M., Daniels B.P., Klein R.S. IL-1R1 signaling regulates CXCL12-mediated T cell localization and fate within the central nervous system during West Nile Virus encephalitis. J Immunol 2014, 193:4095-4106.
54. Durrant D.M., Robinette M.L., Klein R.S. IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis. J Exp Med 2013, 210:503-516.
55. Kaushik D.K., Gupta M., Kumawat K.L., Basu A. NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLOS ONE 2012, 7:e32270.
56. Nair S., Michaelsen-Preusse K., Finsterbusch K., Stegemann-Koniszewski S., Bruder D., Grashoff M., Korte M., Koster M., Kalinke U., Hauser H., et al. Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neurons. PLoS Pathog 2014, 10:e1003999.
57. Harikumar K.B., Yester J.W., Surace M.J., Oyeniran C., Price M.M., Huang W.C., Hait N.C., Allegood J.C., Yamada A., Kong X., et al. K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5. Nat Immunol 2014, 15:231-238.
58. Pan D., Flores O., Umbach J.L., Pesola J.M., Bentley P., Rosato P.C., Leib D.A., Cullen B.R., Coen D.M. A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency. Cell Host Microbe 2014, 15:446-456.
59. Thounaojam M.C., Kaushik D.K., Basu A. MicroRNAs in the brain: it's regulatory role in neuroinflammation. Mol Neurobiol 2013, 47:1034-1044.
60. Thounaojam M.C., Kaushik D.K., Kundu K., Basu A. MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. J Neurochem 2014, 129:143-154.
61. Liang X.H., Kleeman L.K., Jiang H.H., Gordon G., Goldman J.E., Berry G., Herman B., Levine B. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 1998, 72:8586-8596.
62. Shoji-Kawata S., Sumpter R., Leveno M., Campbell G.R., Zou Z., Kinch L., Wilkins A.D., Sun Q., Pallauf K., MacDuff D., et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 2013, 494:201-206.
63. Orvedahl A., MacPherson S., Sumpter R., Talloczy Z., Zou Z., Levine B. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 2010, 7:115-127.
64. Talloczy Z., Jiang W., Virgin HWt, Leib D.A., Scheuner D., Kaufman R.J., Eskelinen E.L., Levine B. Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci U S A 2002, 99:190-195.
65. Orvedahl A., Alexander D., Talloczy Z., Sun Q., Wei Y., Zhang W., Burns D., Leib D.A., Levine B. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 2007, 1:23-35.